Nomura Holdings’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.16M | Buy |
13,343
+12,594
| +1,681% | +$4.67M | 0.01% | 778 |
|
|
2026
Q1 | $219K | Buy |
+749
| New | +$246K | ﹤0.01% | 1558 |
|
|
2025
Q4 | – | Sell |
-7,582
| Closed | -$2.56M | – | 1972 |
|
|
2025
Q3 | $2.45M | Buy |
7,582
+6,777
| +842% | +$2.11M | ﹤0.01% | 1061 |
|
|
2025
Q2 | $313K | Sell |
805
-4,267
| -84% | -$1.72M | ﹤0.01% | 1230 |
|
|
2025
Q1 | $2.21M | Sell |
5,072
-3,263
| -39% | -$1.31M | ﹤0.01% | 1023 |
|
|
2024
Q4 | $3.07M | Buy |
8,335
+5,234
| +169% | +$2.19M | ﹤0.01% | 941 |
|
|
2024
Q3 | $1.61M | Sell |
3,101
-2,993
| -49% | -$1.6M | ﹤0.01% | 1001 |
|
|
2024
Q2 | $3.3M | Buy |
6,094
+4,199
| +222% | +$2.22M | 0.01% | 779 |
|
|
2024
Q1 | $983K | Sell |
1,895
-2,887
| -60% | -$1.44M | ﹤0.01% | 1103 |
|
|
2023
Q4 | $2.25M | Buy |
+4,782
| New | +$2.21M | 0.01% | 917 |
|
|
2023
Q3 | – | Sell |
-46,592
| Closed | -$20.7M | – | 1455 |
|
|
2023
Q2 | $20.7M | Buy |
+46,592
| New | +$21.5M | 0.06% | 214 |
|
|
2022
Q2 | – | Sell |
-44,685
| Closed | -$22.3M | – | 1907 |
|
|
2022
Q1 | $22.3M | Buy |
44,685
+6,300
| +16% | +$2.88M | 0.07% | 173 |
|
|
2021
Q4 | $17.8M | Sell |
38,385
-21,500
| -36% | -$9.05M | 0.05% | 297 |
|
|
2021
Q3 | $22.5M | Buy |
59,885
+1,229
| +2% | +$467K | 0.06% | 202 |
|
|
2021
Q2 | $22.4M | Buy |
58,656
+56,619
| +2,780% | +$21.6M | 0.06% | 197 |
|
|
2021
Q1 | $731K | Sell |
2,037
-72,197
| -97% | -$23.2M | ﹤0.01% | 1220 |
|
|
2020
Q4 | $23.8M | Sell |
74,234
-163,010
| -69% | -$50M | 0.04% | 238 |
|
|
2020
Q3 | $63.8M | Buy |
237,244
+118,891
| +100% | +$32M | 0.14% | 101 |
|
|
2020
Q2 | $31.1M | Buy |
118,353
+106,638
| +910% | +$28.4M | 0.11% | 128 |
|
|
2020
Q1 | $2.66M | Sell |
11,715
-22,861
| -66% | -$6.23M | 0.01% | 414 |
|
|
2019
Q4 | $10.4M | Sell |
34,576
-58,520
| -63% | -$16.1M | 0.04% | 310 |
|
|
2019
Q3 | $22.2M | Buy |
93,096
+88,893
| +2,115% | +$24.4M | 0.08% | 195 |
|
|
2019
Q2 | $1.19M | Sell |
4,203
-46,688
| -92% | -$12.8M | 0.01% | 789 |
|
|
2019
Q1 | $14.7M | Buy |
50,891
+12,675
| +33% | +$3.67M | 0.06% | 231 |
|
|
2018
Q4 | $10M | Buy |
38,216
+24,816
| +185% | +$6.82M | 0.04% | 328 |
|
|
2018
Q3 | $3.7M | Buy |
13,400
+7,060
| +111% | +$1.83M | 0.01% | 567 |
|
|
2018
Q2 | $1.51M | Sell |
6,340
-19,141
| -75% | -$4.43M | ﹤0.01% | 792 |
|
|
2018
Q1 | $5.6K | Buy |
25,481
+6,396
| +34% | +$1.5M | 0.01% | 536 |
|
|
2017
Q4 | $4.3M | Sell |
19,085
-3,783
| -17% | -$806K | 0.01% | 665 |
|
|
2017
Q3 | $4.34M | Sell |
22,868
-4,413
| -16% | -$840K | 0.01% | 588 |
|
|
2017
Q2 | $5.13M | Buy |
+27,281
| New | +$4.9M | 0.01% | 538 |
|
|
2017
Q1 | – | Sell |
-14,535
| Closed | -$2.09M | – | 1362 |
|
|
2016
Q4 | $2.09M | Buy |
14,535
+13,681
| +1,602% | +$1.83M | 0.01% | 842 |
|
|
2016
Q3 | $107K | Sell |
854
-10,650
| -93% | -$1.38M | ﹤0.01% | 1093 |
|
|
2016
Q2 | $1.51M | Buy |
11,504
+436
| +4% | +$59.7K | ﹤0.01% | 702 |
|
|
2016
Q1 | $1.54M | Sell |
11,068
-2,111
| -16% | -$282K | 0.01% | 615 |
|
|
2015
Q4 | $1.84M | Buy |
13,179
+8,420
| +177% | +$1.16M | 0.01% | 701 |
|
|
2015
Q3 | $669K | Sell |
4,759
-14,600
| -75% | -$2.19M | ﹤0.01% | 872 |
|
|
2015
Q2 | $3.18M | Buy |
19,359
+15,491
| +400% | +$2.48M | 0.01% | 614 |
|
|
2015
Q1 | $597K | Sell |
3,868
-20,186
| -84% | -$2.87M | ﹤0.01% | 1001 |
|
|
2014
Q4 | $3.03M | Buy |
24,054
+21,699
| +921% | +$2.68M | 0.01% | 839 |
|
|
2014
Q3 | $280K | Sell |
2,355
-1,650
| -41% | -$189K | ﹤0.01% | 2216 |
|
|
2014
Q2 | $431K | Sell |
4,005
-50,272
| -93% | -$5.18M | ﹤0.01% | 1878 |
|
|
2014
Q1 | $5.41M | Buy |
54,277
+26,272
| +94% | +$2.38M | ﹤0.01% | 718 |
|
|
2013
Q4 | $2.58M | Sell |
28,005
-21,551
| -43% | -$1.91M | 0.01% | 586 |
|
|
2013
Q3 | $4.14M | Buy |
49,556
+23,487
| +90% | +$2.01M | 0.02% | 542 |
|
|
2013
Q2 | $2.13M | Buy |
+26,069
| New | +$1.95M | 0.02% | 655 |
|
Other funds holding ELV
Nomura Holdings's ELV Position: Q2 2026 in Review
Nomura Holdings increased its Elevance Health (ELV) stake by 1,681% in Q2 2026, buying an estimated $4.67M and bringing the position to 13,343 shares worth $5.16M. The position accounts for 0.01% of the portfolio, ranked #778.
Nomura Holdings first reported a position in ELV in Q2 2013 and has held it in 46 quarters since. The position peaked at $63.8M in Q3 2020. 1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Nomura Holdings held 13,343 shares of Elevance Health worth $5.16M as of Q2 2026.
- Nomura Holdings bought 12,594 Elevance Health shares in Q2 2026, an estimated $4.67M.
- Elevance Health made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #778 holding.
- Nomura Holdings first reported a position in Elevance Health in Q2 2013 and has held it in 46 quarters since.
- Nomura Holdings's Elevance Health position peaked at $63.8M in Q3 2020.
- 1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.